Eupraxia Pharmaceuticals: How Targeted Drug Release Addresses Billion-Dollar Markets – Oppenheimer Sees Massive Price Potential

From Systemic to Local Therapy: The Business Model Eupraxia Pharmaceuticals Inc. (EPRX) is a clinical-stage biotechnology company focused on a fundamental challenge in medicine: the effective and low-side-effect delivery of proven drugs. Rather than designing entirely novel molecules with high failure risks, Eupraxia utilizes already approved medications – particularly corticosteroids – and optimizes their delivery. The foundation of this business model is the proprietary Diffusphere technology. This platform enables locally controlled...